• Skip to primary navigation
  • Skip to main content

New York Society of Addiction MedicineNew York Society of Addiction Medicine Logo

  • NYSAM on Twitter
  • NYSAM on Facebook
  • NYSAM on LinkedIn
  • Join Mailing List
  • Past Conferences
  • NYSAM News
  • About
    • About NYSAM
    • Leadership
    • About Addiction Medicine
    • Contact NYSAM
    • News
  • Events
    • 2025 Annual Conference Exhibitors and Sponsors
  • Key Issues
    • Advocacy
    • Opioids
    • Marijuana
    • Access to Care
    • More Issues
  • Resources
    • For Patients
    • For Physicians
    • Webinars
    • Articles
    • Employment
  • Membership
    • NYSAM Committees
    • Become a NYSAM Member
    • Renew Membership
    • Our Members
  • Conferences
  • Latest News
  • Donate
  • Sign Up for Our Newsletter

Opioids

Opioids are a class of medications and substances that primarily affect the mu opioid receptor, in the central nervous system. Opioids comprise natural opiates and synthetic and semi-synthetic opioids. Opioids can have a medical purpose for the treatment of pain, like prescribed opioid medications. Opioids can also have a non-medical purpose such as heroin, a substance that can be ingested, inhaled, or injected.

May 14, 2024 by NYSAM

The Americans with Disabilities Act and the Opioid Crisis

The Americans with Disabilities Act and the Opioid Crisis: Combating Discrimination Against People in Treatment or Recovery The Department of…

May 14, 2024 by NYSAM

Commentary: Expanding access to methadone treatment will save lives

As published in the Times Union By Colleen Parent and Lynda Karig Hohmann May 1, 2024 Measure before Congress would…

April 19, 2024 by NYSAM

Pharmacy Access to Medications to Treat Opioid Use Disorder

ASAM has created a web page for information on pharmacy access for medications to treat substance use disorder. Visit Resource

July 31, 2023 by NYSAM

ASAM Clinical Considerations: Buprenorphine Treatment of OUD for Individuals using High-potency Synthetic Opioids

We’re happy to announce this publication of the American Society of Addiction Medicine Clinical Considerations: Buprenorphine Treatment of OUD for…

June 21, 2023 by NYSAM

Improving Access to Methadone Treatment in the US

by Rachel Simon, MD and Aaron D. Fox, MD MS It was a Friday afternoon and the patient – a…

April 26, 2023 by NYSAM

Pilot Funding Opportunity: One Year Up to $75,000 for Research

One year of pilot funding of up to $75,000 for research into chronic pain and opioid use disorder IMPOWR-ME is…

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

View by Topic

  • All Topics
  • Access to Care
  • Advocacy
  • Alcohol
  • Benzodiazepines
  • Evidence-based Research
  • Harm reduction
  • Marijuana
  • Opioids
  • Stimulants

Connect with Us

  • NYSAM on Twitter
  • NYSAM on Facebook
  • NYSAM on LinkedIn

Join our mailing list to stay updated on upcoming events and chapter news.

  • This field is for validation purposes and should be left unchanged.

NYSAM is a State Chapter of the American Society of Addiction Medicine (ASAM)

  • Become a Member
  • About Addiction Medicine
  • Addiction Resources
  • Physician Resources
  • Key Issues
NYSAM logo in footer

1 Capitol Mall Ste 800
Sacramento, CA 95814

For inquiries, contact Kim Andosca, Executive Director
209-499-9045
nysam@amgroup.us

© 2025 New York Society of Addiction Medicine. Website by Status Forward.